Cerebrospinal fluid biochemical markers in early detection and in differential diagnosis of dementia disorders in routine clinical practice

Improved discrimination of AD patients using β-amyloid _(1-42) and tau levels in CSF

Frank Hulstaert, Kaj Blennow, Adrian Ivanoiu et al. · Neurology · 1999 · 732 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +17

Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice

Niels Andreasen, Lennart Minthon, Pia Davidsson et al. · Archives of Neurology · 2001 · 573 citations

Medicine, Neurology, Neuroscience +17

High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype

Douglas Galasko, L. Chang, Ruth Motter et al. · Archives of Neurology · 1998 · 446 citations

Life Sciences, Neurology, Neuroscience +17

Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

Nancy C. Andreasen, Lennart Minthon, Eugeen Vanmechelen et al. · Neuroscience Letters · 1999 · 242 citations

Medicine, Neurology, Neuroscience +14

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

Nancy C. Andreasen, Eugeen Vanmechelen, A. Van de Voorde et al. · Journal of Neurology Neurosurgery & Psychiatry · 1998 · 229 citations · Full text

Medicine, Neurology, Neuroscience +17